• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红蛋白浓度和血小板计数对非瓣膜性心房颤动患者结局的影响:J-RHYTHM 登记研究的亚组分析。

Impact of hemoglobin concentration and platelet count on outcomes of patients with non-valvular atrial fibrillation: A subanalysis of the J-RHYTHM Registry.

机构信息

Department of Internal Medicine and Cardiology, Nippon Medical School Tama-Nagayama Hospital, Tokyo, Japan.

Saiseikai Toyama Hospital, Toyama, Japan.

出版信息

Int J Cardiol. 2020 Mar 1;302:81-87. doi: 10.1016/j.ijcard.2019.11.127. Epub 2019 Nov 22.

DOI:10.1016/j.ijcard.2019.11.127
PMID:31785960
Abstract

BACKGROUND

To clarify the influence of hemoglobin concentration and platelet count on adverse outcomes of Japanese patients with non-valvular atrial fibrillation (NVAF), a post hoc analysis of the J-RHYTHM Registry was performed.

METHODS

A consecutive series of outpatients with atrial fibrillation were enrolled from 158 institutions and followed up for 2 years or until an event occurred (thromboembolism, major hemorrhage, or all-cause death). Among 7406 patients with NVAF, 6536 with complete blood count data (69.8 ± 9.9 years, 71.0% men) were divided into 4 groups according to the baseline hemoglobin level (<10.0, 10.0-11.9, 12.0-13.9, and ≥14.0 g/dL) or platelet count (<10.0, 10.0-19.9, 20.0-29.9, and ≥30.0 × 10/μL).

RESULTS

Incidence rates of major hemorrhage (p = 0.004 for trend), all-cause death (p < 0.001 for trend), and composite events (p < 0.001 for trend) increased as hemoglobin levels decreased, and composite events (p = 0.045 for trend) increased as platelet counts decreased. After adjusting for multiple confounders, the incidence of all-cause death and composite events was higher with hemoglobin levels <12.0 g/dL than a hemoglobin level ≥14.0 g/dL. In contrast, platelet count was not associated with any events. This was also true when multivariate analysis was performed using the stepwise forward method.

CONCLUSIONS

A low hemoglobin level (<12.0 g/dL) was an independent risk factor for all-cause death and composite events in Japanese patients with NVAF. However, platelet count did not impact outcomes.

CLINICAL TRIAL REGISTRATION

http://www.umin.ac.jp/ctr/ (unique identifier: UMIN000001569).

摘要

背景

为了阐明血红蛋白浓度和血小板计数对日本非瓣膜性心房颤动(NVAF)患者不良结局的影响,对 J-RHYTHM 登记处进行了事后分析。

方法

从 158 家机构连续招募了一系列房颤门诊患者,并进行了 2 年的随访或直至发生事件(血栓栓塞、大出血或全因死亡)。在 7406 例 NVAF 患者中,有 6536 例具有完整的全血细胞计数数据(69.8±9.9 岁,71.0%为男性),根据基线血红蛋白水平(<10.0、10.0-11.9、12.0-13.9 和≥14.0 g/dL)或血小板计数(<10.0、10.0-19.9、20.0-29.9 和≥30.0×10/μL)分为 4 组。

结果

随着血红蛋白水平的降低,大出血(趋势 p=0.004)、全因死亡(趋势 p<0.001)和复合事件(趋势 p<0.001)的发生率增加,随着血小板计数的降低,复合事件(趋势 p=0.045)的发生率增加。在校正了多个混杂因素后,血红蛋白水平<12.0 g/dL 的全因死亡和复合事件发生率高于血红蛋白水平≥14.0 g/dL。相反,血小板计数与任何事件均无关。使用逐步向前法进行多变量分析时也是如此。

结论

低血红蛋白水平(<12.0 g/dL)是日本 NVAF 患者全因死亡和复合事件的独立危险因素。然而,血小板计数对结果没有影响。

临床试验注册

http://www.umin.ac.jp/ctr/(唯一标识符:UMIN000001569)。

相似文献

1
Impact of hemoglobin concentration and platelet count on outcomes of patients with non-valvular atrial fibrillation: A subanalysis of the J-RHYTHM Registry.血红蛋白浓度和血小板计数对非瓣膜性心房颤动患者结局的影响:J-RHYTHM 登记研究的亚组分析。
Int J Cardiol. 2020 Mar 1;302:81-87. doi: 10.1016/j.ijcard.2019.11.127. Epub 2019 Nov 22.
2
Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry.估算肾小球滤过率对非瓣膜性心房颤动患者结局的影响:J-RHYTHM 注册研究的亚组分析。
Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):59-68. doi: 10.1093/ehjqcco/qcx032.
3
Impact of Blood Pressure Visit-to-Visit Variability on Adverse Events in Patients With Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.血压变异性对非瓣膜性心房颤动患者不良事件的影响:J-RHYTHM 登记研究的亚组分析。
J Am Heart Assoc. 2021 Jan 5;10(1):e018585. doi: 10.1161/JAHA.120.018585. Epub 2020 Dec 29.
4
Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J-RHYTHM Registry.非瓣膜性心房颤动患者血压控制对血栓栓塞和大出血的影响:J-RHYTHM 登记研究的亚分析。
J Am Heart Assoc. 2016 Sep 12;5(9):e004075. doi: 10.1161/JAHA.116.004075.
5
Characteristics and outcomes in elderly patients with non-valvular atrial fibrillation and high bleeding risk: subanalysis of the J-RHYTHM Registry.高龄非瓣膜性心房颤动伴高出血风险患者的特征和结局:J-RHYTHM 注册研究的亚组分析。
Heart Vessels. 2024 Apr;39(4):330-339. doi: 10.1007/s00380-023-02343-9. Epub 2023 Dec 16.
6
Use of warfarin in elderly patients with non-valvular atrial fibrillation -- subanalysis of the J-RHYTHM Registry.华法林在老年非瓣膜性心房颤动患者中的应用——J-RHYTHM注册研究的亚组分析
Circ J. 2015;79(11):2345-52. doi: 10.1253/circj.CJ-15-0621. Epub 2015 Sep 1.
7
Impact of Digitalis Use on Mortality in Japanese Patients With Non-Valvular Atrial Fibrillation - A Subanalysis of the J-RHYTHM Registry.洋地黄类药物使用对非瓣膜性心房颤动日本患者死亡率的影响 - J-RHYTHM 注册研究的亚组分析。
Circ J. 2019 Jul 25;83(8):1644-1652. doi: 10.1253/circj.CJ-19-0267. Epub 2019 Jun 19.
8
Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry.房颤透析患者的临床特征及结局:伏见房颤注册研究
Heart Vessels. 2016 Dec;31(12):2025-2034. doi: 10.1007/s00380-016-0818-x. Epub 2016 Mar 14.
9
Renal Dysfunction Affects Anticoagulation Control With Warfarin and Outcomes in Japanese Elderly Patients With Non-Valvular Atrial Fibrillation.肾功能障碍影响日本老年非瓣膜性心房颤动患者华法林抗凝控制和结局。
Circ J. 2018 Aug 24;82(9):2277-2283. doi: 10.1253/circj.CJ-18-0242. Epub 2018 Jul 6.
10
Effect of Addition of a Statin to Warfarin on Thromboembolic Events in Japanese Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus.在日本非瓣膜性心房颤动合并糖尿病患者中,加用他汀类药物至华法林对血栓栓塞事件的影响。
Am J Cardiol. 2017 Jul 15;120(2):230-235. doi: 10.1016/j.amjcard.2017.04.011. Epub 2017 Apr 27.

引用本文的文献

1
Hematological parameters in atrial fibrillation: A literature review.心房颤动的血液学参数:文献综述。
World J Cardiol. 2025 Jul 26;17(7):108363. doi: 10.4330/wjc.v17.i7.108363.
2
Prognostic value of hemoglobin, albumin, lymphocyte, platelet (HALP) scores in patients with non-valvular atrial fibrillation: insights from the AFTER-2 study.血红蛋白、白蛋白、淋巴细胞、血小板(HALP)评分对非瓣膜性心房颤动患者的预后价值:来自AFTER-2研究的见解
BMC Cardiovasc Disord. 2025 Jul 19;25(1):528. doi: 10.1186/s12872-025-04993-1.
3
Low-density lipoprotein cholesterol levels and in-hospital bleeding in patients with atrial fibrillation: findings from CCC-AF project.
心房颤动患者的低密度脂蛋白胆固醇水平与院内出血:CCC-AF项目的研究结果
Front Cardiovasc Med. 2025 Jun 12;12:1574796. doi: 10.3389/fcvm.2025.1574796. eCollection 2025.
4
Association Between Changes in Heart Rate and Adverse Events in Patients With Non-Valvular Atrial Fibrillation: A Post Hoc Analysis of the J-RHYTHM Registry.非瓣膜性心房颤动患者心率变化与不良事件之间的关联:J-RHYTHM注册研究的事后分析
Clin Cardiol. 2025 Apr;48(4):e70122. doi: 10.1002/clc.70122.
5
Correlation between thrombocytopenia and adverse outcomes in patients with atrial fibrillation: a systematic review and meta-analysis.心房颤动患者血小板减少与不良结局的相关性:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2024 Dec 3;11:1383470. doi: 10.3389/fcvm.2024.1383470. eCollection 2024.
6
A Novel Risk Score for Major Bleeding in Japanese Patients with Non-Valvular Atrial Fibrillation: The J-RISK AF Study.日本非瓣膜性心房颤动患者主要出血的新型风险评分:J-RISK AF 研究。
J Atheroscler Thromb. 2024 Nov 1;31(11):1591-1606. doi: 10.5551/jat.64842. Epub 2024 May 28.
7
The association between warfarin usage and international normalized ratio increase: systematic analysis of FDA Adverse Event Reporting System (FAERS).华法林使用与国际标准化比值升高之间的关联:美国食品药品监督管理局不良事件报告系统(FAERS)的系统分析
J Cardiovasc Aging. 2023 Oct;3(4). doi: 10.20517/jca.2023.33. Epub 2023 Oct 17.
8
Characteristics and outcomes in elderly patients with non-valvular atrial fibrillation and high bleeding risk: subanalysis of the J-RHYTHM Registry.高龄非瓣膜性心房颤动伴高出血风险患者的特征和结局:J-RHYTHM 注册研究的亚组分析。
Heart Vessels. 2024 Apr;39(4):330-339. doi: 10.1007/s00380-023-02343-9. Epub 2023 Dec 16.
9
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study.直接口服抗凝剂在合并贫血和/或血小板减少症的心房颤动患者卒中预防中的安全性和有效性:一项回顾性队列研究
Thromb J. 2023 Nov 21;21(1):118. doi: 10.1186/s12959-023-00563-7.
10
Impact of baseline blood pressure on adverse outcomes in Japanese patients with non-valvular atrial fibrillation: the J-RISK AF.基线血压对日本非瓣膜性心房颤动患者不良结局的影响:J-RISK AF研究
Eur Heart J Open. 2022 Dec 16;2(6):oeac081. doi: 10.1093/ehjopen/oeac081. eCollection 2022 Nov.